hydroxyurea and gamma-aminobutyric acid

hydroxyurea has been researched along with gamma-aminobutyric acid in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's3 (60.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J1
Bosboom, WM; Iannaccone, ST; van den Berg, LH; Vrancken, AF; Wadman, RI; Wokke, JH1
Bosboom, WM; Iannaccone, ST; van den Berg, LH; van der Pol, WL; Vrancken, AF; Wadman, RI; Wokke, JH1
Di, XJ; Fu, YL; Han, DY; Mu, TW1
Asselman, FL; Bosboom, WM; Iannaccone, ST; van den Berg, LH; van der Pol, WL; Vrancken, AF; Wadman, RI1

Reviews

3 review(s) available for hydroxyurea and gamma-aminobutyric acid

ArticleYear
Drug treatment for spinal muscular atrophy types II and III.
    The Cochrane database of systematic reviews, 2011, Dec-07, Issue:12

    Topics: Acetylcarnitine; Adolescent; Amines; Child; Child, Preschool; Creatine; Cyclohexanecarboxylic Acids; Gabapentin; gamma-Aminobutyric Acid; Humans; Hydroxyurea; Neuroprotective Agents; Phenylbutyrates; Randomized Controlled Trials as Topic; Spinal Muscular Atrophies of Childhood; Thyrotropin-Releasing Hormone; Valproic Acid

2011
Drug treatment for spinal muscular atrophy types II and III.
    The Cochrane database of systematic reviews, 2012, Apr-18, Issue:4

    Topics: Acetylcarnitine; Adolescent; Amines; Child; Child, Preschool; Creatine; Cyclohexanecarboxylic Acids; Disease Progression; Gabapentin; gamma-Aminobutyric Acid; Humans; Hydroxyurea; Neuroprotective Agents; Phenylbutyrates; Randomized Controlled Trials as Topic; Spinal Muscular Atrophies of Childhood; Thyrotropin-Releasing Hormone; Valproic Acid

2012
Drug treatment for spinal muscular atrophy types II and III.
    The Cochrane database of systematic reviews, 2020, 01-06, Volume: 1

    Topics: Adolescent; Amines; Child; Child, Preschool; Creatine; Cyclohexanecarboxylic Acids; gamma-Aminobutyric Acid; Humans; Hydroxyurea; Neuroprotective Agents; Randomized Controlled Trials as Topic; Spinal Muscular Atrophies of Childhood; Thyrotropin-Releasing Hormone

2020

Other Studies

2 other study(ies) available for hydroxyurea and gamma-aminobutyric acid

ArticleYear
Chemical genetics reveals a complex functional ground state of neural stem cells.
    Nature chemical biology, 2007, Volume: 3, Issue:5

    Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells

2007
Combining valosin-containing protein (VCP) inhibition and suberanilohydroxamic acid (SAHA) treatment additively enhances the folding, trafficking, and function of epilepsy-associated γ-aminobutyric acid, type A (GABAA) receptors.
    The Journal of biological chemistry, 2015, Jan-02, Volume: 290, Issue:1

    Topics: Action Potentials; Adenosine Triphosphatases; Adolescent; Cell Cycle Proteins; Cell Line, Tumor; Chlorides; Drug Synergism; Dynamin I; Endocytosis; Endoplasmic Reticulum; Endoplasmic Reticulum-Associated Degradation; gamma-Aminobutyric Acid; HEK293 Cells; Humans; Hydrazones; Hydroxamic Acids; Hydroxyurea; Myoclonic Epilepsy, Juvenile; Neurons; Patch-Clamp Techniques; Proteasome Endopeptidase Complex; Protein Folding; Protein Stability; Receptors, GABA-A; Signal Transduction; Valosin Containing Protein; Vorinostat

2015